Egetis Therapeutics AB (publ) (EGTX) — Strategic Asset Allocation Index
Egetis Therapeutics AB (publ) (EGTX) has a Strategic Asset Allocation Index of 1.1% as of September 2023. Strategic assets (PP&E of Skr5.00 Million plus long-term investments of Skr-) total Skr5.00 Million, measured against net assets of Skr466.90 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base.
SAAI
Strategic Assets
PP&E
Net Assets
Egetis Therapeutics AB (publ) Strategic Asset Allocation Index (2019–2022)
This chart shows how Egetis Therapeutics AB (publ)'s Strategic Asset Allocation Index has evolved across 4 annual periods from 2019 to 2022. As of September 2023, the index stands at 1.1%, representing strategic assets of Skr5.00 Million against net assets of Skr466.90 Million SEK. Explore Egetis Therapeutics AB (publ) cash flow conversion to assess how effectively this company generates cash.
Annual Strategic Asset Allocation Index for Egetis Therapeutics AB (publ) (2019–2022)
The table below presents the year-by-year Strategic Asset Allocation Index for Egetis Therapeutics AB (publ) from 2019 to 2022, covering 4 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see market value of Egetis Therapeutics AB (publ).
| Year | SAAI | Strategic Assets (SEK) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 0.5% | Skr2.70 Million | Skr2.70 Million | Skr- | Skr506.20 Million | ▼ -0.3 pp |
| 2021 | 0.8% | Skr4.28 Million | Skr4.28 Million | Skr- | Skr527.04 Million | ▲ +0.1 pp |
| 2020 | 0.8% | Skr4.74 Million | Skr4.74 Million | Skr- | Skr629.63 Million | ▲ +0.7 pp |
| 2019 | 0.1% | Skr123.00K | Skr123.00K | Skr- | Skr244.88 Million | — |